XML 31 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Net Income Per Share (Tables)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of computation of basic and diluted net income per share

The following table shows the computation of basic and diluted net income per share for the three and six months ended June 30, 2022 and 2021:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(In thousands except per share data)

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Innoviva stockholders, basic

 

$

939

 

 

$

88,948

 

 

$

16,712

 

 

$

183,071

 

Add: interest expense on 2023 Notes

 

 

570

 

 

 

1,163

 

 

 

1,591

 

 

 

2,367

 

Add: interest expense on 2025 Notes

 

 

1,375

 

 

 

 

 

 

2,539

 

 

 

 

Add: interest expense on 2028 Notes

 

 

1,709

 

 

 

 

 

 

2,093

 

 

 

 

Net income attributable to Innoviva stockholders, diluted

 

$

4,593

 

 

$

90,111

 

 

$

22,935

 

 

$

185,438

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares used to compute basic net income
   per share attributable to Innoviva stockholders

 

 

69,643

 

 

 

88,423

 

 

 

69,594

 

 

 

94,858

 

Dilutive effect of 2023 Notes

 

 

4,866

 

 

 

12,189

 

 

 

7,511

 

 

 

12,189

 

Dilutive effect of 2025 Notes

 

 

11,150

 

 

 

 

 

 

11,150

 

 

 

 

Dilutive effect of 2028 Notes

 

 

9,955

 

 

 

 

 

 

6,360

 

 

 

 

Dilutive effect of options and awards granted under equity
   incentive plan and employee stock purchase plan

 

 

39

 

 

 

27

 

 

 

77

 

 

 

49

 

Weighted-average shares used to compute diluted net income
   per share attributable to Innoviva stockholders

 

 

95,653

 

 

 

100,639

 

 

 

94,692

 

 

 

107,096

 

Net income per share attributable to Innoviva stockholders

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.01

 

 

$

1.01

 

 

$

0.24

 

 

$

1.93

 

Diluted

 

$

0.05

 

 

$

0.90

 

 

$

0.24

 

 

$

1.73

 

Schedule of anti-dilutive securities

The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti-dilutive for the periods presented:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(In thousands)

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Outstanding options and awards granted under equity incentive
   plan and employee stock purchase plan

 

 

642

 

 

 

1,093

 

 

 

514

 

 

 

1,126